Literature DB >> 25821096

The role of narrative medicine in the management of joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type.

Isobel Knight.   

Abstract

Joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type (JHS/EDS-HT) is a hereditary connective tissue disorder affecting every bodily system. It is largely underdiagnosed by many practitioners, with the result of a considerable delay in diagnosis and, consequently, in the onset of adequate management schedule and treatment. Patients may also experience to be misbelieved, erroneously considered affected by a psychiatric or psychosomatic disorders, and rejected by the medical profession, which can lead to feelings of anger and resentment. Patient journeys are often long and complicated, but if doctors allowed the patient time to tell the full story, and were more prepared to think holistically, there may be a far more positive outcome. Here, the patients' perspective is presented with a narrative medicine approach, illustrating the tri-dimensional experience of a JHS/EDS-HT patient, who is also a Bowen Practitioner and a medical writer/educator. Narrative medicine would be invaluable in working with JHS/EDS-HT so that the patient can tell the story, and offer the practitioner a whole picture of her/his suffering and, often, the key for understanding the cause(s). Once this has been achieved, it might be possible to build upon a more positive and therapeutic dialogue which would result in better treatment and more effective management. It is also important for doctors to communicate with JHS/EDS-HT experts who will ultimately improve the patient journey and treatment outcomes of such a complex connective tissue disorder.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Bowen Technique; Ehlers-Danlos syndrome; joint hypermobility syndrome; narrative medicine

Mesh:

Year:  2015        PMID: 25821096     DOI: 10.1002/ajmg.c.31428

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  6 in total

1.  Ehlers-Danlos syndrome hypermobility type is associated with rheumatic diseases.

Authors:  Kyla R Rodgers; Jiang Gui; Mary Beth P Dinulos; Richard C Chou
Journal:  Sci Rep       Date:  2017-01-04       Impact factor: 4.379

2.  Diagnostic needs for rare diseases and shared prediagnostic phenomena: Results of a German-wide expert Delphi survey.

Authors:  Susanne Blöß; Christian Klemann; Ann-Katrin Rother; Sandra Mehmecke; Ulrike Schumacher; Urs Mücke; Martin Mücke; Christiane Stieber; Frank Klawonn; Xiaowei Kortum; Werner Lechner; Lorenz Grigull
Journal:  PLoS One       Date:  2017-02-24       Impact factor: 3.240

3.  Care Is the Doctor's Best Prescription: The Impact of Doctor-Patient Empathy on the Physical and Mental Health of Asthmatic Patients in China.

Authors:  Huiduo Wu; Yan Zhang; Shiyue Li; Qiaoyun Liu; Ningxi Yang
Journal:  Psychol Res Behav Manag       Date:  2020-02-11

4.  The health and life path of rare disease patients: results of the 2015 French barometer.

Authors:  Thomas Heuyer; Sonia Pavan; Christine Vicard
Journal:  Patient Relat Outcome Meas       Date:  2017-09-13

5.  A humanisation approach for the management of Joint Hypermobility Syndrome/Ehlers-Danlos Syndrome-Hypermobility Type (JHS/EDS-HT).

Authors:  Carol J Clark; Isobel Knight
Journal:  Int J Qual Stud Health Well-being       Date:  2017-12

6.  Oral Conditions and Oral Health-Related Quality of Life of People with Ehlers-Danlos Syndromes (EDS): A Questionnaire-Based Cross-Sectional Study.

Authors:  Marcel Hanisch; Moritz Blanck-Lubarsch; Lauren Bohner; Dominik Suwelack; Johannes Kleinheinz; Jeanette Köppe
Journal:  Medicina (Kaunas)       Date:  2020-09-04       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.